文献速递心境障碍会诊联络精神医学

对2461例难治性抑郁症患者的需求、结局与当前治疗路径的混合方法研究

Examining the needs, outcomes and current treatment pathways of 2461 people with treatment-resistant depression: mixed-methods study.
PubMed 文献 · Br J Psychiatry · 2025-03-12

该混合方法研究在英国一家大型多元化国民健康服务信托机构内,整合电子健康记录定量分析与半结构化访谈主题分析,考察难治性抑郁症的临床与服务层面关联。结果显示近半数重性抑郁障碍患者符合难治性抑郁症标准,36.9%曾尝试至少4种抗抑郁药治疗;难治性抑郁症与复发性抑郁、焦虑障碍、人格障碍、自伤及心血管疾病相关,治疗抵抗程度越高与经济活动不活跃和功能丧失增加相关。定性发现揭示严重情绪痛苦、对现有治疗的不满以及组织和疾病相关障碍。

要点

  • 近半数(48%)重性抑郁障碍患者符合难治性抑郁症标准,36.9%曾尝试至少4种抗抑郁药治疗。
  • 难治性抑郁症与复发性抑郁、焦虑障碍、人格障碍、自伤及心血管疾病存在关联。
  • 治疗抵抗程度越高与经济活动不活跃和功能丧失增加相关,定性访谈揭示严重情绪痛苦及对有效照护的组织与疾病相关障碍。

核心结论

  • 难治性抑郁症以精神和躯体共病增加及功能衰退为特征,个体在获得有效照护方面面临障碍,需要改进路径、服务结构以及更有效的生物和心理干预。

研究设计与样本

  • 混合方法研究,整合电子健康记录的定量分析与半结构化访谈的主题分析。
  • 研究在英国一家大型多元化国民健康服务信托机构内开展。
  • 定量分析采用卡方检验和单因素方差分析评估抗抑郁治疗线数与社会人口学和临床变量的关联,并采用二元逻辑回归识别难治性抑郁症状态的关联因素。

主要发现

  • 近半数(48%)重性抑郁障碍患者符合难治性抑郁症标准,36.9%曾尝试至少4种抗抑郁治疗。
  • 难治性抑郁症患者复发性抑郁比例更高(比值比=1.24,95%CI:1.05-1.45,P=0.008)。
  • 难治性抑郁症患者共病焦虑障碍比例更高(比值比=1.21,95%CI:1.03-1.41,P=0.019)。
  • 难治性抑郁症患者共病人格障碍比例更高(比值比=1.35,95%CI:1.10-1.65,P=0.003)。
  • 难治性抑郁症患者自伤(比值比=1.76,95%CI:1.06-2.93,P=0.029)和心血管疾病(比值比=1.46,95%CI:1.02-2.07,P=0.0374)比例更高。

关键数值与推荐

  • 难治性抑郁症通常定义为对至少两种足量足疗程的序贯抗抑郁药治疗无应答。
  • 治疗抵抗程度更高与经济活动不活跃和功能丧失增加相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A substantial subset of patients with major depressive disorder (MDD) experience treatment-resistant depression (TRD), typically defined as failure to respond to at least two sequential antidepressant trials at adequate dose and length. AIMS: To examine clinical and service-level associations of TRD, and the experiences of people with TRD and clinicians involved in their care within a large, diverse National Health Service trust in the UK. METHOD: This mixed-methods study integrated quantitative analysis of electronic health records with thematic analysis of semi-structured interviews. Chi-squared tests and one-way analysis of variance were used to assess associations between lines of antidepressant treatments and sociodemographic and clinical variables, and binary logistic regression was used to identify associations of TRD status. RESULTS: Nearly half (48%) of MDD patients met TRD criteria, with 36.9% having trialled ≥4 antidepressant treatments. People with TRD had higher rates of recurrent depression (odds ratio = 1.24, 95% CI: 1.05-1.45, P = 0.008), comorbid anxiety disorders (odds ratio = 1.21, 95% CI: 1.03-1.41, P = 0.019), personality disorders (odds ratio=1.35, 95% CI: 1.10-1.65, P = 0.003), self-harm (odds ratio = 1.76, 95% CI: 1.06-2.93, P = 0.029) and cardiovascular diseases (odds ratio = 1.46, 95% CI: 1.02-2.07, P = 0.0374). Greater treatment resistance was linked to increased economic inactivity and functional loss. Qualitative findings revealed severe emotional distress and frustration with existing treatments, as well as organisational and illness-related barriers to effective care. CONCLUSIONS: TRD is characterised by increasing mental and physical morbidity and functional decline, with individuals experiencing barriers to effective care. Improved pathways, service structures and more effective biological and psychological interventions are needed.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Gill K, Hett D, Carlish M, et al. Examining the needs, outcomes and current treatment pathways of 2461 people with treatment-resistant depression: mixed-methods study. Br J Psychiatry. 2025. PMID: 40070346. doi:10.1192/bjp.2024.275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。